Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6327537rdf:typepubmed:Citationlld:pubmed
pubmed-article:6327537lifeskim:mentionsumls-concept:C0014644lld:lifeskim
pubmed-article:6327537lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6327537lifeskim:mentionsumls-concept:C0343640lld:lifeskim
pubmed-article:6327537lifeskim:mentionsumls-concept:C0003342lld:lifeskim
pubmed-article:6327537lifeskim:mentionsumls-concept:C0021006lld:lifeskim
pubmed-article:6327537lifeskim:mentionsumls-concept:C1155229lld:lifeskim
pubmed-article:6327537pubmed:issue5lld:pubmed
pubmed-article:6327537pubmed:dateCreated1984-7-3lld:pubmed
pubmed-article:6327537pubmed:abstractTextWe examined whether any immunoglobulin allotype was associated with an elevated risk of Burkitt's lymphoma because of the association between Burkitt's lymphoma and abnormalities of the immunoglobulin-bearing chromosomes. The distribution of Gm and Km phenotypes among 56 Burkitt lymphoma cases and 25 age-matched controls was unremarkable. Burkitt's lymphoma has also been associated with the Epstein-Barr virus, and we therefore sought a relationship between immunoglobulin allotypes and antibody response to the component antigens of the Epstein-Barr virus, VCA, EA-D, EA-R and EBNA. No immunoglobulin phenotype was associated with higher antibody titers against any antigen, but there appeared to be an interactive effect in which persons homozygous at both Gm and Km loci had elevated titers against several of the component antigens of the Epstein-Barr virus. This is the first report of an interactive effect between immunoglobulin allotypes and viruses. Antibody titers against antigens of the Epstein-Barr virus were higher in cases than in controls, as expected. However, female cases had significantly higher titers than male cases, a finding similar to that previously reported in healthy persons.lld:pubmed
pubmed-article:6327537pubmed:languageenglld:pubmed
pubmed-article:6327537pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6327537pubmed:citationSubsetIMlld:pubmed
pubmed-article:6327537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6327537pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6327537pubmed:statusMEDLINElld:pubmed
pubmed-article:6327537pubmed:monthMaylld:pubmed
pubmed-article:6327537pubmed:issn0020-7136lld:pubmed
pubmed-article:6327537pubmed:authorpubmed-author:HenleWWlld:pubmed
pubmed-article:6327537pubmed:authorpubmed-author:LevineP HPHlld:pubmed
pubmed-article:6327537pubmed:authorpubmed-author:BiggarR JRJlld:pubmed
pubmed-article:6327537pubmed:authorpubmed-author:NkrumahF KFKlld:pubmed
pubmed-article:6327537pubmed:authorpubmed-author:PandeyJ PJPlld:pubmed
pubmed-article:6327537pubmed:issnTypePrintlld:pubmed
pubmed-article:6327537pubmed:day15lld:pubmed
pubmed-article:6327537pubmed:volume33lld:pubmed
pubmed-article:6327537pubmed:ownerNLMlld:pubmed
pubmed-article:6327537pubmed:authorsCompleteYlld:pubmed
pubmed-article:6327537pubmed:pagination577-80lld:pubmed
pubmed-article:6327537pubmed:dateRevised2007-7-24lld:pubmed
pubmed-article:6327537pubmed:meshHeadingpubmed-meshheading:6327537-...lld:pubmed
pubmed-article:6327537pubmed:meshHeadingpubmed-meshheading:6327537-...lld:pubmed
pubmed-article:6327537pubmed:meshHeadingpubmed-meshheading:6327537-...lld:pubmed
pubmed-article:6327537pubmed:meshHeadingpubmed-meshheading:6327537-...lld:pubmed
pubmed-article:6327537pubmed:meshHeadingpubmed-meshheading:6327537-...lld:pubmed
pubmed-article:6327537pubmed:meshHeadingpubmed-meshheading:6327537-...lld:pubmed
pubmed-article:6327537pubmed:meshHeadingpubmed-meshheading:6327537-...lld:pubmed
pubmed-article:6327537pubmed:meshHeadingpubmed-meshheading:6327537-...lld:pubmed
pubmed-article:6327537pubmed:meshHeadingpubmed-meshheading:6327537-...lld:pubmed
pubmed-article:6327537pubmed:meshHeadingpubmed-meshheading:6327537-...lld:pubmed
pubmed-article:6327537pubmed:year1984lld:pubmed
pubmed-article:6327537pubmed:articleTitleHumoral immune response to Epstein-Barr virus antigens and immunoglobulin allotypes in African Burkitt lymphoma patients.lld:pubmed
pubmed-article:6327537pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6327537lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6327537lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6327537lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6327537lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6327537lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6327537lld:pubmed